Therefore, the enhancement of Nrf2 expression through pharmacological or genetic approaches could reduce the level of ROS, avoiding the intensification of stress-induced diseases (e.g., acute lung injury, diabetic nephropathy, heart failure and cancer) [37]. Here, NFE2L2 is linked to cancer.